Radiopharm Theranostics RADX
NASDAQ RADX
$1.48 -0.14 (-8.64%)
At close: Oct 1, 2026 · 4:00 PM EDT

Radiopharm Theranostics (RADX) Invested Capital (2024 - 2026)

Updated

Radiopharm Theranostics (RADX) posted Invested Capital of $341,181 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 28.9% from $480,134 a year earlier.

Analysis

Radiopharm Theranostics (RADX) Invested Capital (2024 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Radiopharm Theranostics' Invested Capital came in at $326,659, down 99.6% from FY2025.

  • In prior fiscal years, Radiopharm Theranostics' Invested Capital was $74.97 million in FY2025 and $400,554 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Radiopharm Theranostics 5.74 Bn 5.70 Bn 186,835.86 341,180.94
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 341,180.94
Jun 30, 2025 480,134.23
Dec 31, 2024 81.55 Mn
Jun 30, 2024 400,553.53
API Access

Radiopharm Theranostics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=RADX&period=max&api_key=YOUR_API_KEY